/>
top of page

Welcome!

Captario was founded on a mission to empower pharmaceutical businesses to make more proactive, fast, and insightful decisions. With a vision of revolutionizing pharma decision-making, Captario's focus has consistently been on developing our proprietary SaaS platform, Captario SUM®, supported by in-house scientific research on portfolio optimization to meet the goal of finding a more precise and straightforward solution to drug development modeling.

6-Minute Demo of Captario SUM®

The Conference Team

White Square Initial Monogram Logo.png

John McClure

Head of Client Solutions

john.mcclure@captario.com

blue-color-white-background-linkedin-design-logo-sign-symbol-free-vector.webp
3.png

Anastasia Danopoulou

blue-color-white-background-linkedin-design-logo-sign-symbol-free-vector.webp
19.png

Shaineze Afir

Strategic Decision Lead Analyst

shaineze.afir@captario.com

blue-color-white-background-linkedin-design-logo-sign-symbol-free-vector.webp
2.png

Stephanie Mardini

Key Account Manager
stephanie.mardini@captario.com

blue-color-white-background-linkedin-design-logo-sign-symbol-free-vector.webp
iStock-461202269.jpg
CASE STUDY

COVID-19 Portfolio Impact

Problem

A large pharma company with a robust clinical portfolio started seeing delays with no end to the COVID-19 pandemic in sight and wanted to understand the impact on portfolio value and risk.

Solution

Captario added delay scenarios in our system. Simulations were run with the delay across all projects set at 0, 3, 6, and 9 months and created a number of customized visualizations that specifically addressed the questions at hand. 

Captario's portfolio management solutions for drug development processes allow you to plan for "what-if" scenarios
bottom of page